VISKOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Viskase Holdings, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 3, 2026
$4.05−0.09 (-2.27%)
Close on Oct 19, 2026
- Market cap
- $58.04M
- P/E (TTM)
- –
- Dividend yield
- 0.00%
Share price
+$3.98 (+5,686%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Jun 30, 2026
Valuation
- Market cap
- $58.04M
- P/E ratio
- –
- Price to sales
- –
- Price to book
- 0.31
- Dividend yield
- 0.00%
- Free cash flow yield
- –
Fundamentals
- Net income
- -$13.65M
- EPS, diluted
- -$1.01
- Book value per share
- $13.03
- Diluted shares
- 14M
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
–
Operating income
-$9.12M
Net income
-$13.65M
EPS, diluted
–
Free cash flow
–
Reported periodTrailing twelve months